advanced clinical research services limited
advanced clinical research services limited Company Information
Company Number
11344817
Next Accounts
Sep 2025
Directors
Shareholders
advanced clinical gmbh
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
building 2, guildford business park, guildford, GU2 8XG
Website
www.advancedclinical.comadvanced clinical research services limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CLINICAL RESEARCH SERVICES LIMITED at £6.2m based on a Turnover of £4.3m and 1.44x industry multiple (adjusted for size and gross margin).
advanced clinical research services limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CLINICAL RESEARCH SERVICES LIMITED at £1.8m based on an EBITDA of £310.7k and a 5.69x industry multiple (adjusted for size and gross margin).
advanced clinical research services limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED CLINICAL RESEARCH SERVICES LIMITED at £1.3m based on Net Assets of £703.4k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanced Clinical Research Services Limited Overview
Advanced Clinical Research Services Limited is a live company located in guildford, GU2 8XG with a Companies House number of 11344817. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in May 2018, it's largest shareholder is advanced clinical gmbh with a 100% stake. Advanced Clinical Research Services Limited is a young, small sized company, Pomanda has estimated its turnover at £4.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Advanced Clinical Research Services Limited Health Check
Pomanda's financial health check has awarded Advanced Clinical Research Services Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 3 areas for improvement. Company Health Check FAQs
2 Strong
5 Regular
3 Weak
Size
annual sales of £4.3m, make it in line with the average company (£4.5m)
- Advanced Clinical Research Services Limited
£4.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 67%, show it is growing at a faster rate (13.4%)
- Advanced Clinical Research Services Limited
13.4% - Industry AVG
Production
with a gross margin of 54%, this company has a comparable cost of product (54%)
- Advanced Clinical Research Services Limited
54% - Industry AVG
Profitability
an operating margin of 6.8% make it more profitable than the average company (-4.4%)
- Advanced Clinical Research Services Limited
-4.4% - Industry AVG
Employees
with 48 employees, this is similar to the industry average (54)
48 - Advanced Clinical Research Services Limited
54 - Industry AVG
Pay Structure
on an average salary of £83.2k, the company has an equivalent pay structure (£83.2k)
- Advanced Clinical Research Services Limited
£83.2k - Industry AVG
Efficiency
resulting in sales per employee of £89.3k, this is less efficient (£131.7k)
- Advanced Clinical Research Services Limited
£131.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Advanced Clinical Research Services Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (60 days)
- Advanced Clinical Research Services Limited
60 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Advanced Clinical Research Services Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 18 weeks, this is less cash available to meet short term requirements (30 weeks)
18 weeks - Advanced Clinical Research Services Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 51.8%, this is a similar level of debt than the average (52.5%)
51.8% - Advanced Clinical Research Services Limited
52.5% - Industry AVG
ADVANCED CLINICAL RESEARCH SERVICES LIMITED financials
Advanced Clinical Research Services Limited's latest turnover from December 2023 is estimated at £4.3 million and the company has net assets of £703.4 thousand. According to their latest financial statements, Advanced Clinical Research Services Limited has 48 employees and maintains cash reserves of £269 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 48 | 32 | 14 | 11 | 11 | 4 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 41,403 | 38,696 | 13,849 | 5,977 | 6,486 | 200 |
| Intangible Assets | ||||||
| Investments & Other | 168,266 | |||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | 41,403 | 38,696 | 13,849 | 5,977 | 6,486 | 168,466 |
| Stock & work in progress | ||||||
| Trade Debtors | 284,339 | |||||
| Group Debtors | 1,126,747 | 869,521 | 554,196 | 316,030 | ||
| Misc Debtors | 21,711 | 23,914 | 6,689 | 20,172 | 9,215 | |
| Cash | 268,969 | 115,960 | 71,713 | 106,352 | 30,220 | 19,058 |
| misc current assets | ||||||
| total current assets | 1,417,427 | 1,009,395 | 632,598 | 442,554 | 323,774 | 19,058 |
| total assets | 1,458,830 | 1,048,091 | 646,447 | 448,531 | 330,260 | 187,524 |
| Bank overdraft | ||||||
| Bank loan | ||||||
| Trade Creditors | 1,751 | 933 | 588 | 6,006 | 3,451 | 167,513 |
| Group/Directors Accounts | 32,341 | 6,267 | ||||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | 711,027 | 555,018 | 330,483 | 240,836 | 220,649 | |
| total current liabilities | 745,119 | 562,218 | 331,071 | 246,842 | 224,100 | 167,513 |
| loans | ||||||
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | 10,351 | 7,352 | 2,631 | 1,135 | 1,232 | 38 |
| total long term liabilities | 10,351 | 7,352 | 2,631 | 1,135 | 1,232 | 38 |
| total liabilities | 755,470 | 569,570 | 333,702 | 247,977 | 225,332 | 167,551 |
| net assets | 703,360 | 478,521 | 312,745 | 200,554 | 104,928 | 19,973 |
| total shareholders funds | 703,360 | 478,521 | 312,745 | 200,554 | 104,928 | 19,973 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 20,980 | 11,683 | 5,803 | 4,309 | 3,294 | |
| Amortisation | ||||||
| Tax | ||||||
| Stock | ||||||
| Debtors | 255,023 | 332,550 | 224,683 | 42,648 | 106,230 | 187,324 |
| Creditors | 818 | 345 | -5,418 | 2,555 | -164,062 | 167,513 |
| Accruals and Deferred Income | 156,009 | 224,535 | 89,647 | 20,187 | 220,649 | |
| Deferred Taxes & Provisions | 2,999 | 4,721 | 1,496 | -97 | 1,194 | 38 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | -168,266 | 168,266 | ||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | 26,074 | 6,267 | ||||
| Other Short Term Loans | ||||||
| Long term loans | ||||||
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 153,009 | 44,247 | -34,639 | 76,132 | 11,162 | 19,058 |
| overdraft | ||||||
| change in cash | 153,009 | 44,247 | -34,639 | 76,132 | 11,162 | 19,058 |
advanced clinical research services limited Credit Report and Business Information
Advanced Clinical Research Services Limited Competitor Analysis
Perform a competitor analysis for advanced clinical research services limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in GU2 area or any other competitors across 12 key performance metrics.
advanced clinical research services limited Ownership
ADVANCED CLINICAL RESEARCH SERVICES LIMITED group structure
Advanced Clinical Research Services Limited has no subsidiary companies.
Ultimate parent company
ADVANCED CLINICAL RESEARCH SERVICES LIMITED
11344817
advanced clinical research services limited directors
Advanced Clinical Research Services Limited currently has 1 director, Mr Graham Belgrave serving since Feb 2022.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Graham Belgrave | 62 years | Feb 2022 | - | Director |
P&L
December 2023turnover
4.3m
+45%
operating profit
289.7k
0%
gross margin
54.1%
+1.94%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
703.4k
+0.47%
total assets
1.5m
+0.39%
cash
269k
+1.32%
net assets
Total assets minus all liabilities
advanced clinical research services limited company details
company number
11344817
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
May 2018
age
7
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
WINDSOR ACCOUNTANCY LTD
auditor
GRANT THORNTON
address
building 2, guildford business park, guildford, GU2 8XG
Bank
BNP PARIBAS
Legal Advisor
-
advanced clinical research services limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to advanced clinical research services limited.
advanced clinical research services limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCED CLINICAL RESEARCH SERVICES LIMITED. This can take several minutes, an email will notify you when this has completed.
advanced clinical research services limited Companies House Filings - See Documents
| date | description | view/download |
|---|
